



Thursday, December 7, 2006
2:00 pm – 2:45 pm Keynote Lecture
LESSONS FROM GENETIC FORMS OF OSTEOARTHRITIS FOR CARTILAGE BIOLOGY AND THE
PATHOGENESIS OF OSTEOARTHRITIS
Bjorn R. Olsen, MD, PhD
2:45 pm – 3:45 pm Plenary Session I
2:45 pm – 3:00 pm CAN BIOMARKERS HELP US DETECT, TREAT, AND BETTER UNDERSTAND OSTEOARTHRITIS
Virginia Byers Kraus, MD, PhD
3:00 pm–3:15 pm A1 CARTILAGE MARKERS AND THEIR ASSOCIATION WITH CARTILAGE LOSS ON MRI: THE
BOSTON OSTEOARTHRITIS KNEE STUDY
D.J. Hunter1, J. Li1, M. LaValley1, D.C. Bauer2, M. Nevitt2, J. DeGroot3, R. Poole4, D. Eyre5,
A. Guermazi6, D. Gale1, D.T. Felson1
1Boston University, Boston, MA, 2UCSF, San Francisco, CA, 3TNO, Leiden, The Netherlands, 4McGill
University, Montreal, PQ, Canada, 5University of Washington, Seattle, WA, 6Synarc, San Francisco, CA
3:15 pm–3:30 pm A2 INNATE PRODUCTION OF TUMOR NECROSIS FACTOR-ALFA AND INTERLEUKIN-10 IS
ASSOCIATED WITH PROGRESSION OF KNEE OSTEOARTHRITIS
S.A. Botha-Scheepers, I. Watt, E. Slagboom, A.J. de Craen, I. Meulenbelt, F.R. Rosendaal,
F.C. Breedveld, T.W. Huizinga, M. Kloppenburg
Leiden University Medical Center, Leiden, The Netherlands
3:30 pm – 3:45 pm A3 ONE YEAR FOLLOW-UP OF COLL 2-1, COLL 2-1 NO2 AND MYELOPEROXYDASE SERUM
LEVELS IN OSTEOARTHRITIC PATIENTS AFTER HIP OR KNEE REPLACEMENT
M. Deberg1, A. Labasse1, C. Sanchez1, E. Quettier2, J-E. Dubuc2, A. Bosseloir3, Y. Henrotin1
1University of Liège, Liège, Belgium, 2Hospital Princess Paola, Marche-en-Famenne, Belgium,
3Zentech SA, Liège, Belgium
4:15 pm – 5:45 pm Plenary Session II – OARSI Initiatives
OARSI TREATMENT GUIDELINES FOR HIP AND KNEE OSTEOARTHRITIS
4:15 pm – 5:15 pm Marc C. Hochberg, MD, MPH
Roland Moskowitz, MD
George Nuki, MB, FACP
Weiya Zhang, BSc, MSc, PhD
5:15 pm – 5:30 pm RADIOGRAPHIC ATLAS
Roy D. Altman, MD
5:30 pm – 5:45 pm HISTOPATHOLOGY
Thomas Aigner, MD, DSc
6:00 pm – 8:00 pm OPENING CEREMONY
Welcome from President and Conference Co-Chairs
vi
Osteoarthritis and Cartilage Vol.14, Supplement B vii
LIFETIME ACHIEVEMENT, BASIC AND CLINICAL AWARDS PRESENTATIONS
Recognition of Young Investigator Awards
Award presentations and lectures from recipients
6:15 pm – 6:45 pm Lifetime Achievement Award
Anthony Robin Poole, PhD, DSc
6:45 pm – 7:15 pm Clinical Science Award
Timothy Spector, MD, MSc, FRCP
7:15 pm – 7:45 pm Basic Science Award
Hiroshi Kawaguchi, MD, PhD
8:00 pm – 9:30 pm OPENING RECEPTION WITH EXHIBITS
Friday, December 8, 2006
7:00 am – 8:00 am Breakfast Session A
CLINICAL TRIAL DESIGN
Marc C. Hochberg, MD, MPH
7:00 am – 8:00 am Breakfast Session B
EVALUATION AND VALIDATION OF MICROARRAY DATA IN OSTEOARTHRITIS AND CARTILAGE
RESEARCH
Thomas Aigner, MD, DSc
Ralf Zimmer, PhD
8:30 am – 10:00 am Plenary Session III
PRESENTATION OF HIGHEST-RATED ABSTRACTS
8:30 am – 8:45 am A4 REARFOOT MOBILITY DETERMINES IF VALGUS WEDGED ORTHOSES REDUCE KNEE
ADDUCTION MOMENTS IN MEDIAL KNEE OSTEOARTHRITIS (OA)
R. Lidtke1, B. Goker2, C. Meuhleman1, M. Wimmer1, K. Foucher1, J. Block1
1Rush University Medical Center, Chicago, IL, 2Rheu Gazi University, Ankara, Turkey
8:45 am – 9:00 am A5 OSTEOPHYTES IN MURINE EXPERIMENTAL OSTEOARTHRITIS RESEMBLE TGF-BETA
INDUCED OSTEOPHYTES. THE ROLE FOR BMP IN EARLY OSTEOARTHRITIC OSTEOPHYTE
FORMATION APPEARS TO BE LIMITED
E.N. Blaney Davidson, E.L. Vitters, H. M. van Beuningen, F. A. van de Loo, W. B. van den Berg, P. M.
van der Kraan
University Medical Centre St. Radboud, Nijmegen, The Netherlands
Young Investigator Award Recipient
9:00 am – 9:15 am A6 A PROSPECTIVE RANDOMIZED CLINICAL STUDY OF AUTOLOGOUS OSTEOCHONDRAL
TRANSPLANTATION VERSUS MICROFRACTURE FOR THE TREATMENT OF OSTEOCHONDRAL
DEFECTS IN THE KNEE JOINT IN YOUNG ATHLETES. A 5 YEAR FOLLOW-UP
R. Gudas, E. Stankevicius, E. Monastyreckiene, D. Pranys, A. Smailys
Kaunas Medical University, Kaunas, LITHUANIA
Young Investigator Award Recipient
9:15 am – 9:30 am A7 COMP MUTATIONS AFFECT EXPRESSION PATTERNS OF EXTRACELLULAR MATRIX
PROTEINS DURING IN VITRO CHONDROGENESIS
J.A. Roman-Blas, R.M. Seghatoleslami, A.S. Dion, K. Giunta, P. Oca, F. Han, S.A. Jimenez,
C.J. Williams
Thomas Jefferson University, Philadelphia, PA
viii Scientific Program
9:30 am – 9:45 am A8 TOLL LIKE RECEPTOR 2 AND 4 DO NOT AGGRAVATE JOINT PATHOLOGY IN OSTEOARTHRITIS
A.B. Blom, L.A. Joosten, P. M. van der Kraan, P. L. van Lent, W. B. van den Berg
Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands
Young Investigator Award Recipient
9:45 am – 10:00 am General Q & A
10:00 am – 10:30 am OARSI BUSINESS MEETING
11:00 am – 12:30 pm Concurrent Session I
11:00 am – 11:30 am TRANSCRIPTIONAL REGULATION OF CHONDROCYTE GENE EXPRESSION
Linda Sandell, PhD
11:30 am – 11:45 am A9 NOVEL FUNCTIONS OF THE TIA-1 ARTHRITIS SUPPRESSOR PROTEIN IN REGULATING TYPE
II PROCOLLAGEN GENE EXPRESSION
A. McAlinden, L. Liang, Y. Mukudai, T. Imamura, L.J. Sandell
Washington University, St Louis, MO
Young Investigator Award Recipient
11:45 am – 12:00 pm A10 F-SPONDIN, A NEURONAL DIFFERENTIATION FACTOR, IS UPREGULATED IN
OSTEOARTHRITIS: EVIDENCE FOR REGULATION OF CHONDROCYTE METABOLISM VIA
LATENT TGF-B1 ACTIVATION
M. Attur, G. Palmer, H. Al-Mussawir, D. Rifkin, C. Teixeira, F. Beier, S.B. Abramson
NYU Hospital for Joint Diseases, New York, NY
12:00 pm – 12:15 pm A11 INTEGRIN αVβ5 MAY BE RESPONSIBLE FOR THE SUPPRESSION OF CARTILAGE MATRIX
GENES AND FORMATION OF CYTOSKELETONS DURING DEDIFFERENTIATION IN THE
MONOLAYER CULTURED ADULT HUMAN ARTICULAR CHONDROCYTES
N. Fukui1, Y. Ikeda1, T. Ohnuki1, N. Tanaka1, A. Hikita1, S. Yamane1, R. Suzuki1, T. Ochi1,
Y. Katsuragawa2, S. Yamamoto3
1Clinical Resarch Center, National Hospital Organization Sagamihara Hospital, Sagamihara,
Kanagawa Prefecture, Japan, 2International Medical Center of Japan, Tokyo, Japan, 3Tokyo
Metropolitan Geriatric Hospital, Tokyo, Japan
12:15 pm – 12:30 pm A12 NOTCH PATHWAY IS INVOLVED IN MURINE ARTICULAR CHONDROCYTE DEDIFFERENTIATION
F. Berenbaum1, M. Mahjoub2, C. Salvat2, C. Brou3, M. Corvol4, J-F. Savouret4, F. Rannou4,
P. Bausero2
1Faculty of Medicine P & M Curie, Paris, France, 2UMR CNRS 7079/University P & M Curie, Paris,
France, 3URA 2582 CNRS/Institut Pasteur, paris, France, 4UMR S-530 INSERM/Paris V, Paris, France
11:00 am – 12:30 pm Concurrent Session II
TOTAL ARTICULAR REPLACEMENT: WHAT ARE WE LEARNING FROM
EPIDEMIOLOGICAL STUDIES?
11:00 am – 11:30 am THE INTERNATIONAL GROWTH OF JOINT REPLACEMENT: DEVICES AND DEMOGRAPHICS
Thomas Parker Vail, MD
11:30 am – 12:00 pm A QUALITATIVE APPROACH: WHO IS UNDERGOING TOTAL HIP REPLACEMENTS/TOTAL KNEE
REPLACEMTS: ROLE OF THE HEALTH CARE SYSTEM/PATIENT’S SOCIO-CULTURAL
CHARACTERISTICS
Gillian Hawker, MD, MSc
12:00 pm – 12:30 pm TOTAL ARTICULAR REPLACEMENT: AN OUTCOME MEASURE FOR EVALUATING DMOADS?
Maxime Dougados, MD
12:30 pm – 2:00 pm SATELLITE LUNCH SYMPOSIUM
Sponsored by IBSA
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2:00 pm – 4:00 pm POSTER SESSION I
PRESENTERS IN ATTENDANCE
Posters 60–78 – Animal Models
Posters 79–116 – Biomarkers
Posters 117–125 – Bone Biology
Posters 125–213 – Cartilage Biology
Posters 214–224 – Epidemiology and Health Services Research
4:15 pm – 5:45 pm Concurrent Session III
CYTOKINES, PROTEASES AND GROWTH
4:15 pm – 4:45 pm FACTORS IN THE PATHOPHYSIOLOGY OF OSTEOARTHRITIS: WHAT ARE THEIR LEVELS OF
GUILT?
Johanne Martel-Pelletier, PhD
4:45 pm – 5:00 pm A13 TG2-CATALYZED TRANSAMIDATION OF K3 AND Q102 RESIDUES TRANSFORMS LATENT
S100A11 CALGRANULIN INTO AN INDUCER OF MATRIX CATABOLISM AND HYPERTROPHIC
DIFFERENTIATION IN CHONDROCYTES
D. Cecil, R. Terkeltaub
UCSD/VAMC, San Diego, CA
Young Investigator Award Recipient
5:00 pm – 5:15 pm A14 INJECTED TIMP-3 PROTECTS CARTILAGE IN A RAT MENISCAL TEAR MODEL
R.A. Black1, B. Castner1, J. Slack1, J. Tocker1, J. Eisenman1, E. Jacobson1, J. Delaney1, D. Winters2,
R. Hecht2, A. Bendele3
1Amgen, Seattle, WA, 2Amgen, Thousand Oaks, CA, 3Bolder BioPATH, Boulder, CO
5:15 pm – 5:30 pm A15 ELEVATED EXTRACELLULAR MATRIX PRODUCTION AND GAG DEGRADATION UPON BMP-2
STIMULATION POINT TOWARDS A ROLE FOR BMP-2 IN CARTILAGE REMODELING
E.N. Blaney Davidson, E.L. Vitters, P. L. van Lent, F. A. van de Loo, P. M. van der Kraan, W. B. van den
Berg
University Medical Centre St. Radboud, Nijmegen, The Netherlands
5:30 pm – 5:45 pm A16 DIFFERENTIAL ROLES OF IKKα AND IKKβ IN CHONDROGENESIS AND OA INFLAMMATION
REVEALED BY RETROVIRAL MEDIATED RNA INTERFERENCE
E. Olivotto1, R.M. Borzì1, R. Vitellozzi1, A. Facchini2, M. Battistelli3, M. Penzo4, X. Li5, F. Flamigni2,
J. Li5, E. Falcieri3, M. Uguccioni6, A. Facchini7, K.B. Marcu8
1Istituti Ortopedici Rizzoli, Bologna, Italy, 2Dipartimento di Biochimica, Università degli Studi, Bologna,
Italy, 3Istituto di Scienze Morfologiche, Università degli Studi di Urbino "Carlo Bo", Urbino, Italy,
4Vita-Salute San Raffaele University & DIBIT Institute, Milano, Italy, 5Boehringer Ingelheim
Pharamaceuticals, Ridgefield, CT, 6Istituto di Ricerca in Biomedicina, Bellinzona, Switzerland,
7Dipartimento di Medicina Interna e Gastroenterologia, Università degli Studi, Bologna, Italy,
8Biochemistry Department, SUNY at Stony Brook, Stony Brook, NY
4:15 pm – 5:15 pm Concurrent Session IV
4:15 pm – 4:30 pm HIP OSTEOARTHRITIS: NEW HORIZONS OF SURGERY; THE CONCEPT OF
FEMOROACETABULAR IMPINGEMENT
Reinhold Ganz, MD
4:30 pm – 4:45 pm OSTEOTOMY: JOINT PRESERVATION NOT ONLY IN DYSPLASIA
Siebenrock Klaus, MD
4:45 pm – 5:00 pm IS SURFACE REPLACEMENT AN ALTERNATIVE TO CONVENTIONAL TOTAL HIP
REPLACEMENT?
Peter Grigoris, PhD, FRCS
5:00 pm – 5:15 pm MINIMAL INVASIVE HIP SURGERY: FICTION OR REALITY
Guenther Klaus, MD




Saturday, December 9, 2006
7:00 am – 8:00 am Breakfast Session C
REGULATORY ASPECTS OF IMPLEMENTING IMAGING BIOMARKERS
Brad Wyman, PhD
7:00 am – 8:00 am Breakfast Session D
BIOMECHANICS AND CARTILAGE LUBRICATION
Gerard Ateshian, PhD
8:30 am – 10:00 am Plenary Session IV
8:30 am – 9:00 am IMAGING OF CARTILAGE – CHANGE IN PARADIGMS
Thomas Link, MD
9:00 am – 9:15 am A17 LOCATION SPECIFIC RADIOGRAPHIC JOINT SPACE WIDTH FOR OSTEOARTHRITIS
PROGRESSION: VALIDATION OF A SOFTWARE METHOD
G. Neumann1, D. Hunter2, M. Nevitt3, L.B. Chibnik4, K. Kwoh5, H. Chen6, T. Harris6, S. Satterfield7,
J. Duryea1
1Radiology, Brigham and Women’s Hospital/Harvard Medical School, Boston, MA, 2Clinical
Epidemiology and Research Training Unit, Boston University, Boston, MA, 3Department of Epi and
Biostat, University of California, San Francisco, CA, 4Rheumatology, Brigham and Women’s Hospital/
Harvard Medical School, Boston, MA, 5Medicine, University of Pittsburgh, Pittsburgh, PA, 6IRP,
National Institute on Aging, Baltimore, MD, 7Preventive Medicine, University of Tennesee, Memphis, TN
9:15 am – 9:30 am A18 THE LOSS OF CARTILAGE VOLUME/THICKNESS ON THE WEIGHT BEARING AREAS IN KNEE
OSTEOARTHRITIS PATIENTS, ASSESSED BY QUANTITATIVE MRI, IS CORRELATED WITH
SEVERITY OF SYMPTOMS AND WORSENING OF PAIN OVER TIME
J-P. Raynauld1, J. Martel-Pelletier1, M-J. Berthiaume2, F. Abram3, D. Choquette1, B. Haraoui1,
J. Beary4, G. Cline4, J. Meyer4, J-P. Pelletier1
1Osteoarthritis Research Unit, University of Montreal Hospital Center, Notre-Dame Hospital, Montreal,
PQ, Canada, 2Radiology Department, Maisonneuve-Rosemont Hospital, Montreal, PQ, Canada,
3ArthroVision, Montreal, PQ, Canada, 4Health Care Research Center, Procter & Gamble
Pharmaceuticals, Mason, OH
9:30 am – 9:45 am A19 EARLY CHANGES OF CARTILAGE T2 TIME IN DYSPLASTIC HIPS USING 3.0 T MRI
T. Nishii, N. Sugano, H. Tanaka, T. Sakai, T. Hananouchi, H. Yoshikawa
Osaka University Medical School, Osaka, Japan
9:45 am – 10:00 am A20 PRECISION OF 3 TESLA MR IMAGING OF CARTILAGE MORPHOLOGY IN A MULTICENTER
CLINICAL TRIAL
F. Eckstein1, C.H. Charles2, M. Hudelmaier1, R. Buck3, B. Wyman3, M-P. Hellio Le Graverand3
1Institute of Anatomy, PMU, Salzburg, Austria, 2DIAL, Duke University, Durham, NC, 3Pfizer GRD, Ann
Arbor, MI
8:30 am – 10:00 am Concurrent Session IV-A
Animal Models
8:30 am – 8:45 am A21 SAFETY AND EFFICACY OF NEAR INFRARED LIGHT FOR CARTILAGE RE-GROWTH OF DEEP
OSTEOCHONDRAL DEFETC IN SHEEP AS ANIMAL MODEL
D. Fortuna1, G. Rossi2, B. Grigolo3, R. Buda4, A. Zati5, S. Giannini4, T. Bilotta5, P. Mondardini6,
A. Crovace7, L. Masotti1
1El. En. S.p.A., Calenzano, Florence, Italy, 2Univ. of Camerino, Veterinary Science Dept., Matelica,
Italy, 3Rizzoli Orthopedic Inst., Lab. of Immunology and Genetics, Bologna, Italy, 4Rizzoli Orthopedic
Inst., VI Div. di Chirurgia Ortopedico-Traumatologica, Bologna, Italy, 5Rizzoli Orthopedic Inst., Servizio
di Recupero e Rieducazione Funzionale, Bologna, Italy, 6Sport Medicine Inst. - CONI, Bologna, Italy,
7University of Bari, Dept. of Emergency and Organ Transplantation, Valenzano (Bari), Italy
Young Investigator Award Recipient
8:45 am – 9:00 am A22 THE RELATIONSHIP BETWEEN SUBCHONDRAL BONE AND CARTILAGE VOLUME IN A
NON-HUMAN PRIMATE MODEL OF OSTEOARTHRITIS
J.M. Blair, C. E. Watts, H.M. Metcalfe, A.D. Nicholson, O.A. Okojie
National Institutes of Health, Bethesda, MD
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9:00 am–9:15 am A23 MESENCHYMAL CELLS/POLYLACTIC ACID SCAFFOLD CONSTRUCT FOR THE REPAIR OF
OSTEOCHONDRAL LESIONS
Y. Oshima1, H.L. Frederick1, R.S. Goomer1, T. Kubo2, D. Amiel1
1University of California San Diego, La Jolla, CA, 2Kyoto Prefectural University of Medicine, Kyoto,
Japan
Young Investigator Award Recipient
9:15 am – 9:30 am A24 MURINE SURGICALLY-INDUCED OSTEOARTHRITIS IS SEX AND STRAIN DEPENDENT
S.S. Glasson, T. Blanchet, B. Hopkins, M. Ma, D. Peluso, M. Rivera-Bermudez, E.A. Morris
Wyeth, Cambridge, MA
9:30 am – 9:45 am A25 COLLAGEN TYPE II DEGRADATION AND FORMATION ASSESSED IN EX VIVO AND IN VIVO IN
MODELS OF RA
A.K. Olsen1, R.H. Nielsen1, B-C. Sondergaard1, P. Qvist1, C. Christiansen2, M.A. Karsdal1
1Nordic Bioscience, Herlev, Denmark, 2CCBR, Ballerup, Denmark
9:45 am – 10:00 am A26 DEVELOPMENT OF A NEW CANINE MODEL OF OSTEOARTHRITIS: THE GROOVE MODEL
S.C. Mastbergen1, J. DeGroot2, F.P. Lafeber1
1University Medical Center Utrecht, Utrecht, The Netherlands, 2Business Unit Biomedical Research
TNO Quality of Life, Leiden, The Netherlands
10:30 am – 12:00 pm Concurrent Session V
10:30 am – 11:00 am NOVEL MEDIATORS OF CHONDROCYTE GENE EXPRESSION DURING CHONDROGENESIS
AND DEVELOPMENT OF OSTEOARTHRITIS
Mary B. Goldring, PhD
11:00 am – 11:15 am A27 CHONDROCYTE SENESCENCE IN OSTEOARTHRITIS
K. Yudoh, K. Masuko, T. Kato, K. Nishioka
St. Marianna University School of Medicine, Kawasaki City, Japan
11:15 am – 11:30 am A28 A 2D-LC/MS/MS APPROACH TO IN VITRO JOINT INJURY BIOMARKERS AND BIOLOGY
A.L. Stevens, J.S. Wishnok, S.R. Tannenbaum, A.J. Grodzinsky
Massachusetts Institute of Technology, Cambridge, MA
11:30 am – 11:45 am A29 A REDUCED EXPRESSION OF CARTILAGE OLIGOMERIC MATRIX PROTEIN (COMP) IN
CULTURED OSTEOARTHRITIC CHONDROCYTES CAN BE ASCRIBED TO A LOSS OF THE CELL
CHONDROGENIC DIFFERENTIATION POTENTIAL
P. Giannoni1, R. Narcisi2, R. Cancedda2
1Biorigen srl, Genova, Italy, 2Lab.Regenerative Medicine, Natl.Inst. for Cancer Research, Genova, Italy
11:45 am – 12:00 pm A30 HYPOXIC EXPANSION OF ARTICULAR CHONDROCYTES PROMOTES THE FORMATION OF A
HYALINE CARTILAGE-LIKE MATRIX IN MICROMASS CULTURES
R.J. Egli1, R. Ganz2, W. Hofstetter1, M. Leunig3
1University of Bern, Department Clinical Research, Bern, Switzerland, 2Balgrist University Hospital,
Department of Orthopedics, Zurich, Switzerland, 3Schulthess Clinics, Orthopedics, Zurich, Switzerland
10:30 am – 12:00 pm Concurrent Session VI
10:30 am – 11:00 am UPDATE OF GENETICS OF OSTEOARTHRITIS
Timothy Spector, MD, MSc, FRCP
11:00 am – 11:15 am A31 BLOOD LEAD LEVELS ARE ASSOCIATED WITH MORE SEVERE RADIOGRAPHIC KNEE
OSTEOARTHRITIS
J.M. Jordan, F. Fang, J.B. Renner, J-C. Chen
University of North Carolina, Chapel Hill, NC
11:15 am – 11:30 am A32 DIETARY VITAMIN D INTAKE AND RADIOGRAPHIC KNEE OSTEOARTHRITIS
N.K. Arden, A. Richardson, H.E. Syddall, A. Aihie Sayer, E.M. Dennison, C. Cooper
MRC Epidemiology Resource Centre, University of Southampton, Southampton, United Kingdom
11:30 am – 11:45 am A33 A SNP LOCATED DOWNSTREAM OF BMP5 IS ASSOCIATED WITH ALLELIC EXPRESSION
IMBALANCE AT THE GENE AND WITH PRIMARY OSTEOARTHRITIS
J. Loughlin, L. Southam, Z. Mustafa, B. Dowling, J. Wilkins, S. Snelling, K. Chapman
University of Oxford, Oxford, United Kingdom
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11:45 am – 12:00 pm A34 RISK PREDICTION OF KNEE OSTEOARTHRITIS USING MULTIPLE GENES
A.M. Valdes1, G.L. Surdulescu1, M. Doherty2, T.D. Spector1
1St Thomas Hospital, London, United Kingdom, 2Academic Rheumatology Unit, University of
Nottingham, City Hospital, Nottingham, United Kingdom
1:30 pm – 3:30 pm POSTER SESSION II
PRESENTERS IN ATTENDANCE
Posters 225–237 – Epidemiology and Health Services Research
Posters 238–250 – Genetics and Genomics
Posters 251–291 – Imaging
Posters 292–321 – Non-Surgical Treatment of OA
Posters 322–350 – Osteoarthritis Clinical Aspects
Posters 351–362 – Pain and Disability
Posters 363–370 – Surgical Treatment of OA
Posters 371–378 – Synovial Tissue Biology
Posters 379–394 – Tissue Engineering and Repair
3:45 pm – 5:15 pm Concurrent Session VII
3:45 pm – 4:15 pm MUSCLE STEM CELLS EXPRESSING BMP4 FOR CARTILAGE REPAIR
Johnny Huard, PhD
4:15 pm – 4:30 pm A35 RECOMIBINANT HUMAN CARTILAGE-DERIVED RETINOIC ACID SENSITIVE PROTEIN (CD-RAP)
- A NOVEL TREATMENT OPTION FOR OSTEOARTHRITIS
S.D. Pippig, K. Hellerbrand, C. Dony
Scil Technology, Martinsried, Germany
4:30 pm – 4:45 pm A36 MODULATION OF COLLAGEN NETWORK FORMATION TO IMPROVE FUNCTIONAL
PROPERTIES IN CARTILAGE REGENERATION
Y.M. Jenniskens1, W. Koevoet1, A.C. De Bart2, J.A. Verhaar1, H. Weinans1, G. J. van Osch1,
J. DeGroot2
1Erasmus MC, University Medical Center, Rotterdam, The Netherlands, 2TNO Quality of Life, Leiden,
The Netherlands
4:45 pm – 5:00 pm A37 CARTILAGE ENGINEERING AND REPAIR: CONTRIBUTION OF HUMAN
GLYCOSYLTRANSFERASES IN THE BIOSYNTHESIS OF MATRIX GLYCOSAMINOGLYCANS
J. Magdalou, S. Gulberti, M. Fondeur-Gelinotte, L. Barré, V. Lattard, C. Bui, P. Netter, N. Venkatesan,
S. Fournel-Gigleux, M. Ouzzine
UMR 7561 CNRS-Université Henri Poincaré Nancy 1, Vandoeuvre-lès-Nancy, France
5:00 pm – 5:15 pm A38 MODELLING SUBSTRATE MASS-TRANSPORT DURING MESENCHYMAL STEM CELL-BASED
CARTILAGE TISSUE ENGINEERING
J.F. Welter, H. Baskaran, L.A. Solchaga, V. Goldberg
Case Western Reserve University, Cleveland, OH.
3:45 pm – 5:15 pm Concurrent Session VIII
3:45 pm – 4:15 pm DEVELOPMENT OF NEW STRATEGIES AND AGENTS WITH STRUCTURE MODIFYING
POTENTIAL IN OSTEOARTHRITIS
Jean-Pierre Pelletier, MD
4:15 pm – 4:30 pm A39 TREATMENT OF KNEE OSTEOARTHRITIS WITH AUTOLOGOUS CONDITIONED SERUM (ACS)
A.W. Baltzer1, R. Krauspe2, C. Moser2
1Centre for molecular Orthopaedics, Duesseldorf, Germany, 2Orthopaedic Department; University
Hospital Duesseldorf, Duesseldorf, Germany
4:30 pm – 4:45 pm A40 DYNAMIC WEDGING: A NOVEL METHOD FOR TREATING KNEE OSTEOARTHRITIS
Y. Bar-Ziv, Y. Beer, Y. Ran, S. Benedict, N. Halperin
Asaf Harofe Medical Center, Tel Aviv, Israel
4:45 pm – 5:00 pm A41 TREATMENT EFFECTS ARE MORE DIFFICULT TO DETECT IN OSTEOARTHRITIS PATIENTS
WHO FLARE AT STUDY ENTRY DUE TO INCREASED PLACEBO RESPONSE - A GAIT REPORT
D.J. Reda1, H. Shi1, D.O. Clegg2, for the GAIT Investigators
1VA Cooperative Studies Program, Hines, IL, 2University of Utah, Salt Lake City, UT
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5:00 pm – 5:15 pm A42 MANAGEMENT OF SYMPTOMATIC HAND OA (HOA) PATIENTS IN AMBULATORY PRACTICE IN
FRANCE: A CROSS-SECTIONAL SURVEY
E. Maheu1, P. Coste2, A. Lafuma3, R-L. Dreiser4
1St Antoine Hospital, Paris, France, 2Expanscience Laboratories, Courbevoie, France, 3CEMKA -
EVAL, Bourg La Reine, France, 4Bichat Hospital, Paris, France
5:45 pm – 7:15 pm Concurrent Session IX
5:45 pm – 6:15 pm BIO-REACTORS AND OSTEOCHONDRAL/CARTILAGE REPAIR
Ivan Martin, PhD
6:15 pm – 6:30 pm A43 THE SAFETY AND EFFICACY OF ROUTINE PERI-OPERATIVE NSAIDS PROPHYLAXIS FOR
ECTOPIC BONE FORMATION AFTER HIP REPLACEMENT SURGERY (HIPAID). A RANDOMISED
CLINICAL TRIAL
The HIPAID Collaborative Group, M. Fransen
The George Institute, Camperdown, Australia
6:30 pm – 6:45 pm A44 ASSOCIATION BETWEEN HOSPITAL AND SURGEON VOLUME AND PATIENT REPORTED
OUTCOMES FOLLOWING REVISION TOTAL KNEE REPLACEMENT
J.N. Katz1, N.N. Mahomed2, J.W. Wright1, A.H. Fossel1, E.A. Wright1, J.A. Baron3, J. Barrett3,
E. Losinà1
1Brigham and Women’s Hospital, Boston, MA, 2University of Toronto, Toronto, ON, Canada,
3Dartmouth Medical School, Lebanon, NH
6:45 pm – 7:00 pm A45 ECONOMIC CONSIDERATIONS OF VOLUME-OUTCOMES RELATIONSHIP FOR ELECTIVE
SURGICAL PROCEDURES: COST-EFFECTIVENESS OF TOTAL KNEE REPLACEMENT AT HIGH
VS. LOWER VOLUME CENTERS
E. Losina1, J.N. Katz2
1Boston University School of Public Health, Boston, MA, 2Brigham and Women’s Hospital, Boston, MA
7:00 pm – 7:15 pm A46 EARLY OUTCOME AFTER TOTAL HIP REPLACEMENT VARIES BY FUNCTION, PAIN AND
NUMBER OF CO-MORBID CONDITIONS PRIOR TO SURGERY
S. Schaeren1, J.F. Huber2, R. Theiler3, E. Gautier4, B. Jolles5, W. Dick1, H.A. Bischoff-Ferrari6
1University Hospital, Basel, Switzerland, 2Kantonsspital, Aarau, Switzerland, 3Stadtspital Triemli,
Zurich, Switzerland, 4Hôpital cantonal, Fribourg, Switzerland, 5University Hospital, Lausanne,
Switzerland, 6University Hospital, Zurich, Switzerland
5:45 pm – 7:15 pm Concurrent Session X
5:45 pm – 6:15 pm PAIN IN OSTEOARTHRITIS
Hans-Georg Schaible, MD
6:15 pm – 6:30 pm A47 THE RELATIONSHIP BETWEEN STATIC LOWER LIMB ALIGNMENT AND DYNAMIC KNEE
VARUS MOMENT IN PATIENTS OF KNEE OSTEOARTHRITIS DEPENDS ON DISEASE GRADE
K. Naito1, W. Kakihana1, R. Kuramochi2, S. Torii2, K. Akita3, K. Nakazawa1, M. Akai1, T. Fukubayashi2
1National Rehabilitation Center for Persons with Disabilities, Tokorozawa, Japan, 2Waseda University,
Facurity of Sports Sciences, Tokorozawa, Japan, 3Waseda University, Graduate School of Sports
Sciences, Tokorozawa, Japan
6:30 pm – 6:45 pm A48 MEDIAL COMPARTMENT LOADING AND WEAK HIP ABDUCTORS IN PATIENTS WITH KNEE OA:
A PILOT STUDY OF THE EFFECT OF HIP STRENGTHENING ON JOINT LOADING
M.A. Wimmer, L.E. Thorp, K.C. Foucher, D.R. Sumner, J.A. Block
Rush University Medical Center, Chicago, IL
6:45 pm – 7:00 pm A49 CLINICAL SYMPTOMS, FUNCTION, AND ACTIVITY LEVELS CORRELATE WITH MENISCUS
LOSS DURING MENISCECTOMY
W.G. Rodkey1, K.K. Briggs1, J. Steadman2
1Steadman Hawkins Research Foundation, Vail, CO, 2Steadman Hawkins Clinic, Vail, CO
7:00 pm – 7:15 pm A50 RN624 (ANTI-NERVE GROWTH FACTOR ANTIBODY) EFFECTIVELY REDUCES PAIN AND
IMPROVES FUNCTION IN SUBJECTS WITH KNEE OSTEOARTHRITIS
M. Mokhtarani, C. Zhao, M. Gray, C. Chan, F. Hefti
Rinat Neuroscience, South San Francisco, CA
8:30 pm – 12:00 am CONGRESS DINNER at Francouzska Restaurace
xiv Scientific Program
Sunday, December 10, 2006
7:00 am – 8:00 am Breakfast Session E
NEW METHODS FOR MOLECULAR DISCOVERY IN OSTEOARTHRITIS: A FOCUS ON CELL
SIGNALING
Richard F. Loeser Jr., MD
Breakfast Session F
MRI IN OSTEOARTHRITIS, USEFUL FOR THE RESEARCHER AND CLINICIAN
Philip Conaghan, MD, PhD, FRACP, FRCP
8:30 am – 10:00 am Concurrent Session XI
8:30 am – 9:00 am METALLOPROTEINASES & AGGRECANASE IN CARTILAGE DEGRADATION
John Sandy, PhD
9:00 am – 9:15 am A51 CHONDROCYTE MMP-13 EXPRESSION IN RESPONSE TO ALPHA5BETA1 INTEGRIN
STIMULATION REQUIRES PROTEIN SULFENIC ACIDS AS SIGNALING INTERMEDIATES
R.F. Loeser1, R. Yammani1, E. Erickson1, B. King2, L. Poole1
1Wake Forest Universtiy School of Medicine, Winston Salem, NC, 2Wake Forest Universtiy, Winston
Salem, NC
9:15 am – 9:30 am A52 A NOVEL ACTIVATOR OF MMPS IN CARTILAGE
C. Little, M. Jackson, M. Smith, C. Jackson
University of Sydney, St Leonards, Australia
9:30 am – 9:45 am A53 MECHANICAL INJURY POTENTIATES THE COMBINED EFFECTS OF TNF-α AND IL-6/sIL-6R ON
PROTEOGLYCAN CATABOLISM IN BOVINE CARTILAGE
Y. Sui1, X-Y. Song2, J.H. Lee2, M. DiMicco1, S.M. Blake1, H-H. Hung1, I. James2, M.W. Lark2,
A.J. Grodzinsky1
1Massachusetts Institute of Technology, Cambridge, MA, 2Centocor R&D, Inc., Radnor, PA
9:45 am – 10:00 am A54 SALMON CALCITONIN STIMULATE THE PROTEOGLYCAN CONTENT IN HUMAN OA
ARTICULAR CARTILAGE AND PROTECTS AGAINST CARTILAGE EROSION IN VIVO
B-C. Sondergaard1, S.H. Madsen1, S. Oestergaard1, C. Pedersen2, P. Qvist1, M.A. Karsdal1
1Nordic Bioscience Diagnostics, Herlev, Denmark, 2Orthopeadic Surgey Unit Nordjylland, Farsoe,
Denmark
8:30 am – 10:00 am Concurrent Session XII
OMERACT-OARSI INITIATIVE
8:30 am – 9:00 am PAIN SEVERITY SCORING SYSTEM
Gillian Hawker, MD, MSc
9:00 am – 9:30 am FUNCTION SEVERITY SCORING SYSTEM
Aileen Davis, PhD
9:30 am – 10:00 am STRUCTURE SEVERITY SCORING SYSTEM
Laure Gossec, MD
10:30 am – 12:00 pm Concurrent Session XIII
10:30 am – 11:00 am CELLULAR AND MOLECULAR PATHOGENETIC EVENTS IN INTERVERTEBRAL DISC
DEGENERATION
Tony Freemont, MD, FRCPath
11:00 am – 11:15 am A55 LUMBAR DISC DISEASE SHOWS LINKAGE TO CHROMOSOME 19
F.M. Williams1, B.S. Kato1, G. Livshits2, P.N. Sambrook3, T.D. Spector1, A.J. MacGregor4
1King’s College London, London, United Kingdom, 2Tel Aviv University Medical School, Tel Aviv, Israel,
3Institute of Bone and Joint Research, Sydney, Australia, 4University of East Anglia, Norwich, United
Kingdom
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11:15 am – 11:30 am A56 ANK/ANK MOUSE, AN OSTEOARTHRITIS MODEL
F. Las Heras1, R. Inman2, F. Tsui2, K. Pritzker1
1Mount Sinai Hospital, Toronto, ON, Canada, 2Toronto Western Research Institute, Toronto, ON,
Canada
11:30 am – 11:45 am A57 CHONDROGENESIS OF INFRAPATELLAR FAT PAD AND SYNOVIAL MEMBRANE CELLS IN
COMPARISON TO ARTICULAR CARTILAGE CHONDROCYTES
P.D. Clegg, A. Vaughan-Thomas, C. Redmond, N. Rhodes, J. Innes
The University of Liverpool, Neston, United Kingdom
11:45 am – 12:00 pm A58 PREVALENCE OF RADIOGRAPHIC OSTEOARTHRITIS OF KNEE AND LUMBAR SPINE, AND ITS
ASSOCIATION WITH PAIN: THE RESEARCH ON OSTEOARTHRITIS AGAINST DISABILITY
(ROAD) STUDY
H. Kawaguchi1, N. Yoshimura1, S. Muraki1, H. Oka1, A. Mabuchi1, Y. En-yo2, M. Yoshida2, A. Saiga2,
T. Suzuki3, H. Yoshida3, H. Ishibashi3, S. Yamamoto3, K. Nakamura1
1University of Tokyo, Tokyo, Japan, 2Wakayama Medical University, Wakayama, Japan, 3Tokyo
Metropolitan Institute of Gerontology, Tokyo, Japan
10:30 am – 12:00 pm Concurrent Session XIV
SYMPTOMATIC SLOW ACTING DRUGS IN OSTEOARTHRITIS:




Burkhard F. Leeb, MD
GLUCOSAMINE
Karel Pavelka, MD, PhD
CHONDROITIN SULPHATE
B.A. Michel, MD
Panel Discussants
Roland Moskowitz, MD
